TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
Findings advance knowledge in diagnostics research
January 17th, 2006
Reports from Argentina, Germany and the United States highlight recent research on diagnostics. Study 1: A nitrate reductase assay determines rifampin and isoniazid susceptibility from sputum samples. According to recent research published in the Journal of Clinical Microbiology, "Current methods for drug susceptibility testing of Mycobacterium tuberculosis are either costly or slow. "As the prevalence of multidrug-resistant strains increases, the need for fast, reliable, and inexpensive methods that can also be applied in settings with scarce resources is obvious." H.R. Musa and colleagues at...
Source: TB & Outbreaks Week (2006-01-17)
|
